EPO induces changes in synaptic transmission and plasticity in the dentate gyrus of rats
- PMID: 26860222
- DOI: 10.1002/syn.21895
EPO induces changes in synaptic transmission and plasticity in the dentate gyrus of rats
Abstract
Erythropoietin has shown wide physiological effects on the central nervous system in animal models of disease, and in healthy animals. We have recently shown that systemic EPO administration 15 min, but not 5 h, after daily training in a water maze is able to induce the recovery of spatial memory in fimbria-fornix chronic-lesioned animals, suggesting that acute EPO triggers mechanisms which can modulate the active neural plasticity mechanism involved in spatial memory acquisition in lesioned animals. Additionally, this EPO effect is accompanied by the up-regulation of plasticity-related early genes. More remarkably, this time-dependent effects on learning recovery could signify that EPO in nerve system modulate specific living-cellular processes. In the present article, we focus on the question if EPO could modulate the induction of long-term synaptic plasticity like LTP and LTD, which presumably could support our previous published data. Our results show that acute EPO peripheral administration 15 min before the induction of synaptic plasticity is able to increase the magnitude of the LTP (more prominent in PSA than fEPSP-Slope) to facilitate the induction of LTD, and to protect LTP from depotentiation. These findings showing that EPO modulates in vivo synaptic plasticity sustain the assumption that EPO can act not only as a neuroprotective substance, but is also able to modulate transient neural plasticity mechanisms and therefore to promote the recovery of nerve function after an established chronic brain lesion. According to these results, EPO could be use as a molecular tool for neurorestaurative treatments.
Keywords: EPO; LTD; LTP; neural plasticity; synaptic plasticity.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
A unique erythropoietin dosage induces the recovery of long-term synaptic potentiation in fimbria-fornix lesioned rats.Brain Res. 2023 Jan 15;1799:148178. doi: 10.1016/j.brainres.2022.148178. Epub 2022 Nov 26. Brain Res. 2023. PMID: 36442648
-
Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.Neurobiol Dis. 2014 Feb;62:8-17. doi: 10.1016/j.nbd.2013.08.016. Epub 2013 Sep 17. Neurobiol Dis. 2014. PMID: 24055213
-
Erythropoietin improves object placement recognition memory in a time dependent manner in both, uninjured animals and fimbria-fornix-lesioned male rats.Horm Behav. 2018 Apr;100:94-99. doi: 10.1016/j.yhbeh.2018.03.006. Epub 2018 Mar 23. Horm Behav. 2018. PMID: 29548782
-
LTD, LTP, and the sliding threshold for long-term synaptic plasticity.Hippocampus. 1996;6(1):35-42. doi: 10.1002/(SICI)1098-1063(1996)6:1<35::AID-HIPO7>3.0.CO;2-6. Hippocampus. 1996. PMID: 8878740 Review.
-
Cannabinoid function in learning, memory and plasticity.Handb Exp Pharmacol. 2005;(168):445-77. doi: 10.1007/3-540-26573-2_15. Handb Exp Pharmacol. 2005. PMID: 16596784 Review.
Cited by
-
Pre-Treatment with Erythropoietin Attenuates Bilateral Renal Ischemia-Induced Cognitive Impairments.Iran J Pharm Res. 2018 Spring;17(2):601-612. Iran J Pharm Res. 2018. PMID: 29881418 Free PMC article.
-
Developmental Biology in Central America, the northern region of South America and the Caribbean.Int J Dev Biol. 2021;65(1-2-3):49-58. doi: 10.1387/ijdb.200232jg. Int J Dev Biol. 2021. PMID: 32930372 Free PMC article. Review.
-
Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.Trials. 2018 Apr 19;19(1):234. doi: 10.1186/s13063-018-2627-2. Trials. 2018. PMID: 29673379 Free PMC article.
-
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease.Front Cell Dev Biol. 2021 Jul 28;9:703084. doi: 10.3389/fcell.2021.703084. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34395432 Free PMC article. Review.
-
Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.Pharmaceuticals (Basel). 2020 Nov 26;13(12):424. doi: 10.3390/ph13120424. Pharmaceuticals (Basel). 2020. PMID: 33255969 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous